Literature DB >> 24412674

Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.

Brian O'Neill1, Michael R Tilley2, Dawn D Han2, Keerthi Thirtamara-Rajamani1, Erik R Hill3, Georgia A Bishop4, Fu-Ming Zhou5, Matthew J During6, Howard H Gu7.   

Abstract

Cocaine's main pharmacological actions are the inhibition of the dopamine, serotonin, and norepinephrine transporters. Its main behavioral effects are reward and locomotor stimulation, potentially leading to addiction. Using knock-in mice with a cocaine-insensitive dopamine transporter (DAT-CI mice) we have shown previously that inhibition of the dopamine transporter (DAT) is necessary for both of these behaviors. In this study, we sought to determine brain regions in which DAT inhibition by cocaine stimulates locomotor activity and/or produces reward. We used adeno-associated viral vectors to re-introduce the cocaine-sensitive wild-type DAT in specific brain regions of DAT-CI mice, which otherwise only express a cocaine-insensitive DAT globally. Viral-mediated expression of wild-type DAT in the rostrolateral striatum restored cocaine-induced locomotor stimulation and sensitization in DAT-CI mice. In contrast, the expression of wild-type DAT in the dorsal striatum, or in the medial nucleus accumbens, did not restore cocaine-induced locomotor stimulation. These data help to determine cocaine's molecular actions and anatomical loci that cause hyperlocomotion. Interestingly, cocaine did not produce significant reward - as measured by conditioned place-preference - in any of the three cohorts of DAT-CI mice with the virus injections. Therefore, the locus or loci underlying cocaine-induced reward remain underdetermined. It is possible that multiple dopamine-related brain regions are involved in producing the robust rewarding effect of cocaine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Cocaine; Dopamine; Locomotion; Reward; Transporter

Mesh:

Substances:

Year:  2014        PMID: 24412674      PMCID: PMC4011184          DOI: 10.1016/j.neuropharm.2013.12.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  30 in total

1.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.

Authors:  M S Mazei; C P Pluto; B Kirkbride; E A Pehek
Journal:  Brain Res       Date:  2002-05-17       Impact factor: 3.252

2.  Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine.

Authors:  S E Hemby; G H Jones; J B Justice; D B Neill
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

5.  Amphetamine-induced locomotion in a hyperdopaminergic ADHD mouse model depends on genetic background.

Authors:  Brian O'Neill; Howard H Gu
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

6.  Cortical dopaminergic involvement in cocaine reinforcement.

Authors:  N E Goeders; J E Smith
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

7.  Encoding of both positive and negative reward prediction errors by neurons of the primate lateral prefrontal cortex and caudate nucleus.

Authors:  Wael F Asaad; Emad N Eskandar
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

8.  Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats.

Authors:  L Mao; J Q Wang
Journal:  Pharmacol Biochem Behav       Date:  2000-09       Impact factor: 3.533

Review 9.  The role of dopamine in drug abuse viewed from the perspective of its role in motivation.

Authors:  G Di Chiara
Journal:  Drug Alcohol Depend       Date:  1995-05       Impact factor: 4.492

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  11 in total

1.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

Review 2.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

Review 3.  Dopamine transporter mutant animals: a translational perspective.

Authors:  Evgeniya V Efimova; Raul R Gainetdinov; Evgeny A Budygin; Tatyana D Sotnikova
Journal:  J Neurogenet       Date:  2016-03       Impact factor: 1.250

4.  A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.

Authors:  Mark J Ferris; Erin S Calipari; Jamie H Rose; Cody A Siciliano; Haiguo Sun; Rong Chen; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2015-02-18       Impact factor: 7.853

5.  Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.

Authors:  Linda D Simmler; Allison M J Anacker; Michael H Levin; Nina M Vaswani; Paul J Gresch; Alex G Nackenoff; Noelle C Anastasio; Sonja J Stutz; Kathryn A Cunningham; Jing Wang; Bing Zhang; L Keith Henry; Adele Stewart; Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

6.  Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure.

Authors:  Abla Benleulmi-Chaachoua; Alan Hegron; Marine Le Boulch; Angeliki Karamitri; Marta Wierzbicka; Victoria Wong; Igor Stagljar; Philippe Delagrange; Raise Ahmad; Ralf Jockers
Journal:  Cell Mol Life Sci       Date:  2018-07-24       Impact factor: 9.261

7.  Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter.

Authors:  Haiyin Wu; Brian O'Neill; Dawn D Han; Keerthi Thirtamara-Rajamani; Yanlin Wang; Howard H Gu
Journal:  Neuropharmacology       Date:  2014-05-13       Impact factor: 5.250

8.  Poly (ADP-Ribose) Polymerase-1 (PARP-1) Induction by Cocaine Is Post-Transcriptionally Regulated by miR-125b.

Authors:  Sabyasachi Dash; Muthukumar Balasubramaniam; Tanu Rana; Arthur Godino; Emily G Peck; Jeffery Shawn Goodwin; Fernando Villalta; Erin S Calipari; Eric J Nestler; Chandravanu Dash; Jui Pandhare
Journal:  eNeuro       Date:  2017-08-18

9.  Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms.

Authors:  Danielle Krout; Meghan Rodriquez; Stephen A Brose; Mikhail Y Golovko; L Keith Henry; Brent J Thompson
Journal:  ACS Chem Neurosci       Date:  2016-12-28       Impact factor: 4.418

Review 10.  Ethanol actions on the ventral tegmental area: novel potential targets on reward pathway neurons.

Authors:  Chang You; Bertha Vandegrift; Mark S Brodie
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.